Sinclair Research Center is a nonclinical contract research organization (CRO) offering animal efficacy models, IND-enabling and specialty toxicology services and compliant research capabilities to support biopharmaceutical, animal health and medical device development programs. Sinclair is experienced in all research models and the undisputed experts in miniature swine. With more than 50 years’ experience, Sinclair has emerged as a leader in diabetes, dermal, otic and animal health research services with streamlined quality systems supporting both VICH and GLP compliant studies and SEND reporting with no backlog. On January 4, 2022, Sinclair Research became part of Altasciences to further our mission of advancing global health through early phase drug development. Altasciences is a drug development solution company offering pharmaceutical and biotechnology companies of all sizes a proven, flexible approach to preclinical and early phase clinical studies, from lead candidate selection to proof of concept. For over 25 years, Altasciences has been integrating into clients’ projects to help support educated, faster, and more complete early drug development decisions. Altasciences’ full-service solutions include preclinical safety testing, clinical pharmacology, bioanalysis, drug formulation and manufacturing, program management, medical writing, biostatistics, and data management, all of which can be tailored to specific sponsor requirements. At Altasciences, we help sponsors get better drugs to the people who need them faster. We are always available and always looking ahead — moving in unison to deliver big impact with a personal touch. Stay connected by following Altasciences on LinkedIn: https://www.linkedin.com/company/altasciences